SCHEMBL959202

SCHEMBL959202

CC(O)Oc1ccc(CC(=O)C(C)O)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.54
PARP10 Q53GL7 1/20 0.41
CNR2 P34972 1/20 0.40
HTT P42858 1/20 0.40
TDP1 Q9NUW8 3/20 0.39
ATM Q13315 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
FFAR1 O14842 1/20 0.39
LMNA P02545 2/20 0.38
ADRB2 P07550 1/20 0.38
ADRB1 P08588 1/20 0.38
CNR1 P21554 1/20 0.38
ADRA1D P25100 1/20 0.38
ADRA1A P35348 1/20 0.38
ADRA1B P35368 1/20 0.38
KDM4E B2RXH2 1/20 0.38
CYP1A2 P05177 1/20 0.38
GLA P06280 1/20 0.38
CYP3A4 P08684 1/20 0.38
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7153440 0.84 POLB (0.77) POLBPARP10CNR2HTTTDP1
SCHEMBL7713616 0.84 POLB (0.56) POLBCNR2HTTFFAR1LMNA
SCHEMBL108145 0.77 CA2 (0.54) LMNA
SCHEMBL5433337 0.77 LTA4H (0.47) POLBPARP10LMNACYP1A2
SCHEMBL12667396 0.76 POLB (0.71) POLBPARP10CNR2LMNAKDM4E
SCHEMBL10977168 0.76 PARP10 (0.48) POLBPARP10TDP1LMNACYP1A2
SCHEMBL97898 0.76 PARP10 (0.48) POLBPARP10TDP1LMNACYP1A2
SCHEMBL17961880 0.76 PARP10 (0.48) POLBPARP10TDP1LMNACYP1A2
SCHEMBL8361506 0.75 PPARG (0.49) POLBPARP10HTTLMNACYP1A2
SCHEMBL4725179 0.75 TSHR (0.55) POLBCNR2L3MBTL1CYP1A2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8858998-B2 Thermoresponsive arginine-based hydrogels as biologic carriers CORNELL UNIVERSITY (US) 2014-10-14 US disclosed
US-20110008441-A1 THERMORESPONSIVE ARGININE-BASED HYDROGELS AS BIOLOGIC CARRIERS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2011-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110008441-A1 THERMORESPONSIVE ARGININE-BASED HYDROGELS AS BIOLOGIC CARRIERS PARG, PNISR, PUF60 POLB 3172/4885PARP10 1073/4885CNR2 835/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.